Evidence map›Paper›PMID 39444189›Full record

ArticleHIV medicine2025

HIV postnatal prophylaxis and infant feeding policies vary across Europe: results of a Penta survey.

Georgina Fernandes, Elizabeth Chappell, Tessa Goetghebuer, Christian R Kahlert, Santa Ansone, Stefania Bernardi, Guido Castelli Gattinara, Elena Chiappini, Catherine Dollfus, Pierre Frange and 16 more

Abstract read
In one paragraph

Article in HIV medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Georgina FernandesPopulation, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.ORCID https://orcid.org/0000-0003-2056-8376
Elizabeth ChappellMRC Clinical Trials Unit at UCL, London, UK.ORCID https://orcid.org/0000-0003-1053-6434
Tessa GoetghebuerHôpital Saint Pierre, Université Libre de Bruxelles, Brussels, Belgium.
Christian R KahlertInfectious Diseases and Hospital Epidemiology, Children's Hospital of Eastern Switzerland, St. Gallen, Switzerland.ORCID https://orcid.org/0000-0002-0784-3276
Santa AnsoneOutpatient Department, Riga East University Hospital, Latvian Centre of Infectious Diseases, Riga, Latvia.
Stefania BernardiSimplex Unit: Perinatal and Complex Infectious Disease - University Paediatric Clinical Area, Bambino Gesù Children's Hospital, Rome, Italy.
Guido Castelli GattinaraSimplex Unit: Perinatal and Complex Infectious Disease - University Paediatric Clinical Area, Bambino Gesù Children's Hospital, Rome, Italy.
Elena ChiappiniInfectious Diseases Unit, Meyer Children's University Hospital IRCCS, Florence, Italy.ORCID https://orcid.org/0000-0002-1476-4752
Catherine DollfusService d'Hémato-Oncologie Pédiatrique, APHP, Hopital Trousseau, Paris, France.
Pierre FrangeLaboratory of Clinical Microbiology, Necker Enfants Malades Hospital, Groupe hospitalier APHP. Centre - Université Paris Cité, Paris, France.ORCID https://orcid.org/0000-0002-4920-8369
Bridget FreyneDepartment of Paediatric Infectious Diseases Children's Health Ireland, Dublin, Ireland.
Luisa GalliInfectious Diseases Unit, Meyer Children's University Hospital IRCCS, Florence, Italy.
Vania GiacometDepartment of Paediatrics, Paediatric Infectious Disease Unit, L Sacco Hospital, University of Milan, Milan, Italy.
Galia Grisaru-SoenPediatric Infectious Diseases Unit, Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Christoph KönigsDepartment of Paediatrics and Adolescent Medicine, Goethe University, University Hospital Frankfurt, Frankfurt, Germany.
Hermione LyallPaediatric Infectious Diseases, Imperial College Healthcare NHS Trust, London, UK.
Magdalena MarczynskaDepartment of Children's Infectious Diseases Medical University of Warsaw, Warsaw, Poland.
Mariana MardarescuPediatric Department, National Institute for Infectious Diseases 'Prof. Dr. Matei Bals', Bucharest, Romania.
Lars NaverDepartment of Pediatrics, Karolinska University Hospital and Division of Pediatrics, Department of Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
Tim NiehuesDepartment of Pediatrics, Helios Klinikum Krefeld, Krefeld, Germany.
Antoni Noguera-JulianInfectious Diseases and Systemic Inflammatory Response in Pediatrics, Pediatric Infectious Diseases Department, Institut de Recerca Sant Joan de Déu, Hospital Sant Joan de Déu, Barcelona, Spain.
Kim StolDepartment of Pediatrics, Radboud University Nijmegen Medical Center, Amalia Children's Hospital, Nijmegen, The Netherlands.
Alla VolokhaDepartment of Pediatrics, Pediatrics Infectious Diseases, Immunology and Allergology Shupyk National Healthcare University of Ukraine, Kyiv, Ukraine.
Steven B WelchDepartment of Paediatrics Heartlands Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Claire ThornePopulation, Policy and Practice Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, London, UK.ORCID https://orcid.org/0000-0003-0389-1956
Alasdair BamfordMRC Clinical Trials Unit at UCL, London, UK.

Funding

Fondazione Penta ETS
6 · The paper itself

Abstract

objectivesThis survey was conducted to describe current European postnatal prophylaxis (PNP) and infant feeding policies with the aim of informing future harmonized guidelines.

methodsA total of 32 senior clinicians with relevant expertise, working in 20 countries within the European Region, were invited to complete a REDCap questionnaire between July and September 2023.

resultsTwenty-three of the 32 invited paediatricians responded, representing 16/20 countries. There were multiple respondents from the same country for Italy (n = 5), the UK (n = 2), Germany (n = 2) and France (n = 2). All countries use risk stratification to guide PNP regimen selection. Nine out of 16 countries reported three risk categories, six out of 16 reported two, and one country reported differences in categorization. Criteria used to stratify risk varied between and within countries. For the lowest risk category, the PNP regimen reported ranged from no PNP to up to four weeks of one drug; the drug of choice reported was zidovudine, apart from one country which reported nevirapine. For the highest risk category, the most common regimen was zidovudine/lamivudine/nevirapine (20/23 respondents); regimen duration varied from two to six weeks with variation in recommended dosing. Guidelines support breastfeeding for infants born to people living with HIV in eight out of 16 countries; in the other eight, guidelines do not support/specify.

conclusionsGuidelines and practice for PNP and infant feeding vary substantially across Europe and within some countries, reflecting the lack of robust evidence. Effort is needed to align policies and practice to reflect up-to-date knowledge to ensure the vertical transmission risk is minimized and unnecessary infant HIV testing and PNP avoided, while simultaneously supporting families to make informed decisions on infant feeding choice.

Indexed as

Anti-HIV AgentsBreast FeedingHIV InfectionsInfectious Disease Transmission, VerticalPostnatal CareEuropeFemaleHumansInfantInfant, NewbornMalePregnancySurveys and QuestionnairesAnti-HIV AgentsbreastfeedingHIVpaediatricspolicypostnatal prophylaxisvertical transmission

Identifiers

PMID39444189
PMCPMC11786621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.